["{\n\"step_by_step_thinking\": \"The patient has been taking clozapine for 2 weeks and is experiencing improvement. The relevant document mentioning the risk of agranulocytosis with clozapine suggests that a complete blood count (CBC) should be monitored weekly while taking this medication. Since the patient's physical exam is unremarkable, there is no indication to order an electrocardiogram or slit-lamp examination. A prolactin level test may be relevant for another medication, but not specifically related to clozapine.\",\n\"answer_choice\": \"D\""]